PS.
PublicSupply

NHS Framework - Blood Disorders including Haemophilia A and B - July 2024

NHS EnglandcontractFind a Tender ↗Ref ocds-h6vhtk-043b0e32014L0024active
View buyer

Estimated value

—

goods

Awarded value

—

Suppliers

31

2 SME

Lots

23

33 awarded

Published

11 Jun 2024

Total lots

23

Awarded

23

0 pending

Estimated total

£23

Awarded total

—

Lot 1cancelled

CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 3 suppliers
PL
Pfizer Ltd
TU
Takeda UK Ltd
OL
Octapharma Limited
Lot 2cancelled

CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Lot 3cancelled

CM/PHS/22/5661/03 Emicizumab

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
RP
Roche Products Ltd
Lot 4cancelled

CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL)

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
SO
Sobi (Swedish Orphan Biovitrum Ltd)
SME
Lot 5cancelled

CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL)

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
CB
CSL Behring UK Ltd
Lot 6cancelled

CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL)

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
NN
Novo Nordisk
Lot 7cancelled

CM/PHS/22/5661/07 rFIX - Standard Half Life

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 2 suppliers
PL
Pfizer Ltd
TU
Takeda UK Ltd
Lot 8cancelled

CM/PHS/22/5661/08 Recombinant Factor VII

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 2 suppliers
NN
Novo Nordisk
LF
LFB
Lot 9cancelled

CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
TU
Takeda UK Ltd
Lot 10cancelled

CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
TU
Takeda UK Ltd
Lot 11cancelled

CM/PHS/22/5661/11 Factor IX - High Purity Factor IX

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
BP
Bio Products Laboratory Ltd
Lot 12cancelled

CM/PHS/22/5661/12 Factor X

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
BP
Bio Products Laboratory Ltd
Lot 13cancelled

CM/PHS/22/5661/13 Factor XIII - Plasma Derived

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
CB
CSL Behring UK Ltd
Lot 14cancelled

CM/PHS/22/5661/14 Factor XIII - Recombinant

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
NN
Novo Nordisk
Lot 15cancelled

CM/PHS/22/5661/15 Von willebrands factor / Factor VIII

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 2 suppliers
OL
Octapharma Limited
CB
CSL Behring UK Ltd
Lot 16cancelled

CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
LF
LFB
Lot 17cancelled

CM/PHS/22/5661/17 Von willebrands factor - Recombinant

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
TU
Takeda UK Ltd
Lot 18cancelled

CM/PHS/22/5661/18 Fibrinogen Concentrate

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 3 suppliers
LF
LFB
OL
Octapharma Limited
CB
CSL Behring UK Ltd
Lot 19cancelled

CM/PHS/22/5661/19 Prothrombin Complex dried

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Lot 20cancelled

CM/PHS/22/5661/20 Protein C Concentrate

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
TU
Takeda UK Ltd
Lot 21cancelled

CM/PHS/22/5661/21 Fresh Frozen Plasma (all blood groups)

Award value
—

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
Awarded to 1 supplier
OL
Octapharma Limited
Lot 22cancelled

CM/PHS/22/5661/22 Freeze Dried Plasma

Estimated
£1

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
No suppliers awarded yet for this lot.
Lot 23cancelled

CM/PHS/22/5661/23 Caplacizumab

Estimated
£1

Start

30 Jun 2024

End

30 Apr 2027

Estimated

£1

CPV

33600000
No suppliers awarded yet for this lot.